A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors.
- DOI
- 10.1021/acsmedchemlett.1c00448
- Published
- 2022 Mar 10
- Container
- ACS medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acsmedchemlett.1c00448,
title = {A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors.},
author = {Liang R and Tomita D and Sasaki Y and Ginn J and Michino M and Huggins DJ and Baxt L and Kargman S and Shahid M and Aso K and Duggan M and Stamford AW and DeStanchina E and Liverton N and Meinke PT and Foley MA and Phillips RE},
year = {2022},
journal = {ACS medicinal chemistry letters},
doi = {10.1021/acsmedchemlett.1c00448},
url = {https://doi.org/10.1021/acsmedchemlett.1c00448}
}RIS
TY - JOUR TI - A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors. AU - Liang R AU - Tomita D AU - Sasaki Y AU - Ginn J AU - Michino M AU - Huggins DJ AU - Baxt L AU - Kargman S AU - Shahid M AU - Aso K AU - Duggan M AU - Stamford AW AU - DeStanchina E AU - Liverton N AU - Meinke PT AU - Foley MA AU - Phillips RE PY - 2022 JO - ACS medicinal chemistry letters DO - 10.1021/acsmedchemlett.1c00448 UR - https://doi.org/10.1021/acsmedchemlett.1c00448 ER -
APA
R, L., D, T., Y, S., J, G., M, M., DJ, H., L, B., S, K., M, S., K, A., M, D., AW, S., E, D., N, L., PT, M., MA, F., & RE, P. (2022). A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors.. ACS medicinal chemistry letters. https://doi.org/10.1021/acsmedchemlett.1c00448
Source records
- pubmed · retrieved 2026-09-26T08:04:52.324Z